Human Exposure Monitoring, Dosimetry, and Cancer Risk Assessment: The Use of Antisera Specific for Carcinogen-DNA Adducts and Carcinogen-Modified DNA
Author:
- 1 January 1994
- journal article
- review article
- Published by Taylor & Francis in Drug Metabolism Reviews
- Vol. 26 (1-2) , 87-109
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Polycyclic aromatic hydrocarbon—DNA adducts in white blood cells from lung cancer patients: no correlation with adduct levels in lungCarcinogenesis, 1992
- Immunological and HPLC detection of aflatoxin adducts in human tissues after an acute poisoning incident in S.E. AsiaCarcinogenesis, 1991
- Reduced DNA adduct formation in replicating liver cells during continuous feeding of a chemical carcinogen.Proceedings of the National Academy of Sciences, 1990
- Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patientsCarcinogenesis, 1990
- Modern Methods of DNA Adduct Determination1990
- Chromosome site-specific immunohistochemical detection of DNA adducts in N-acetoxy-2-acetylaminofluorene-exposed chinese hamster ovary cellsMolecular Carcinogenesis, 1990
- Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: A preliminary reportGastroenterology, 1989
- Alkyl and aryl carcinogen adducts detected in human peripheral lungCarcinogenesis, 1989
- Detection of Carcinogen–Macromolecular Adducts in HumansJournal of the American College of Toxicology, 1989
- The use of carcinogen‐DNA adduct antisera for quantitation and localization of genomic damage in animal models and the human populationEnvironmental Mutagenesis, 1984